||EPS - Basic
||Market Cap (m)
Access Intelligence Share Discussion Threads
Showing 1926 to 1950 of 1950 messages
|AI ControlPoint Ltd is a great business with an incredibly talented team that will undoubtedly flourish under the ownership of One Voice AS. We have enjoyed every minute of supporting our customers with their crisis management needs and wish them well under the new owners."I heard that the new owners visited the York office and sacked the vast majority of the staff today. So much for this BS underhand management|
|There's nothing left. How is it not bad?A corporate PR company is all that is left of this once tech heavy business.Next movesMove York office to basic small premise.Pretty much a cash shell for a future MJ and JA flight of fancy.All in my humble opinion of course.This one is dead.|
|I don't think it necessarily bad - just surprising at the timing and lack of detail.|
|I always thought that was a jewel in the crown!!!|
|Wow that's so bad.|
|Late day RNS and no details on the financial terms of the sale....what is going on???|
|Lewis - thanks for that, you are quite correct the resignation would appear to have been frim AI Track Record. I was aware of the interest in AI by ACC but surprised they may spend so much effort given there is only a 20% holding.|
|Lewis - Having spoken to someone very close to the company albeit some time ago it was felt that it would be a long slog but they would get there. In the meantime JA and MJ resigned from the Trailight Board on 1 July 2016, hopefully they felt it would be more meaningful to spend their time with ACC|
|The warning sign is no new news in a year. Nothing much left really. I think this one will wilt away. Track record has a better chance or trailight as it's now known but may struggle as JA is on the board of that also.Don't buy into that the management have invested heavily. I would imagine they have taken large salaries at the expense of the shareholder value.Just my opinion.|
|Thanks for your reply DGWinterbottom. I will continue to hold on the hope that some really good news appears in the not too distant future.|
|Gemenian - I very much understand your sentiments however given Michael Jackson has invested significantly both company wise and personally I think he would be looking to get a decent return on his investment. Similarly is the case with CEO Joanna Arnold she too has invested a significant sum in the business so I think the incentive may be there to make it a success to some degree.|
|Anybody know if there is ever going to be an upward and improving share price and giving dividends, or is this going to be another one of these Jam tomorrow companies always finding a reason not to move forward?
have held these for a few years now and keep hearing everything is improving without any real corresponding evidence.|
|Jimbob it appears the ongoing restructuring is not doing anything for shareholder value!|
|Nope. WTF happened? Any thoughts? This rate will be back in 2s again...|
|Could this be the next gbg|
|Access Intelligence – some future value to be had for the patient in the AIM back waters? Read Nigel Somerville
There's only one investor show where really serious investors meet really serious speakers like Slater & Wray - UK Investor April 30th HERE
Noting the disclosure that I own shares in AIM-listed Access Intelligence (LSE:ACC), so I am talking my own book, I was interested to peruse the numbers for the year to November 2015 as released yesterday. The headline numbers look great: revenue from continuing operations up 89%, recurring revenue from continuing operations nigh-on doubled and there was plenty of cash. How do things look beneath the surface?
The first thing which I noticed was that there was no reference to EBITDA to be found anywhere. That sets Access apart from some of the racier constituents of AIM – and the lack of bulletin board activity, as well as the coma-like market activity bodes well. Is this a company in which nobody is interested and thus a potential source of profit for the patient investor?
The hard numbers are that the company saw £3.2 million head! off to money heaven – around 1.55p per share. There was also a net operational cash outflow of £1.6 million and a further £2.0 million outflow from investing activities. This was offset by £1.2 million raised from share issues (including the exercise of options), and £2.9 million raised from the issue of loan notes, to leave the company with cash of £1.5 million at year-end, although net current assets were negative to the tune of £1.2 million.
That doesn’t sound all that promising, but it is not Placing Ahoy for post year-end the company racked up £4.5 million in cash from the disposal of a non-core asset (Due North). The company still has assets on the balance sheet which it is looking to offload, so perhaps there may be more of this to come. Meanwhile, the sale price of £4.5 million represented a multiple of 12.6 times EBITDA and 25 times pre-tax profit. (Oops, I mentioned EBITDA!)
And so to the continuing operations. The company has been undergoing something of a transformation for what feels like an eternity under Chairman Michael Jackson (formerly of FTSE100 company Sage, SGE) and I’ve not really followed it all that closely for some time. From memory, the shares are somewhere around where they were when I bought in.
But here is what interests me: with turnover from continuing operations up by 89% year-on-year and clocking up a gro! ss profit of £4.8 million (vs £3.3 million) before being trashed by admin expenses (£7.3 million, vs £3.9 million last time) and impairments of £1.9 million there does appear to be scope for optimism: one would hope that the impairments will not be an ongoing issue and that the whopping admin expenses might come down.
Meanwhile, if the growth continues in similar vein and those admin and sales costs are kept under control then it does look as though it might not be too long before the company starts to generate cash from its operations, rather than relying on placings, disposals and loans. It won’t be this year, though – we are promised further investment and restructuring during 2016. But we are also told that the full benefits [are] expected to come through towards the end of the current financial year and into 2017.
I’m not saying it is a buy – not yet, at any rate. But Access Intelligence looks like one to watch and research for the patient investor. For those with a taste for researching boring investments which nobody is interested in, this might be a good place to spend some time.|
|That was how I read it too Lanzarote. I assume the cash balance in the accounts is for the year end. If it is not I will have some questions for the AGM.|
|I thought the sale of Due North has come as a post balance sheet event and will show up in November 2016 results. Have I read that wrong?
I am working on next year recurring revenues of £7.50m at 60% margin less overhead say £4.0m (without R&D) of which £948k is depreciation, so cash positive?|
|The other thing too was the EBITDA seemed to be a little buried in the RNS which seems a little odd. Guess it just wasnt worth shouting about|
|They sold Due North to Proactis for £4.5mill and they have 1.5 mill cash left.
The burn is a little scary.
Make or break year I suspect. Interestingly Proactis have a chart that I wish we had here. Hope the sale of Due North wasn't a mistake, time will tell I suppose.|
|But the large purchases that have followed the results announcement may reflect the fact that amongst the losses is an increase in the cash balances and the outlook is better based upon 92% recurring revenues.
Perhaps the jam is getting closer?|
|Results announcement - always seems to be the golden tomorrow!!|
|Don't be fooled. I bought in this week but my purchase showed as a sale at 5p rather than a buy. It seems that some of those transactions at the same level over recent days may have been buyers too.
I did pick up shares easily, so perhaps there is a seller around.
I wonder if I have arrived too late given the run up since June 2015, but am attracted by the level of recurring revenues and absence of R&D cost next year which should feed through to the bottom line. And then the re-rating begins.
|There you go. Happy?|
|Why does this share not drop despite lots of sales over the last month. Is someone buying these.|